Glaukos's ROI from its second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Glaukos's ROI in the second quarter of 2026?
Glaukos Corp recorded a cumulative net loss of $-188 million during 12 months ending in the second quarter of 2026, resulting in a negative return on investment (ROI) of -22.61%.

Within the Healthcare sector 31 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the first quarter of 2026 from 2030 to 3293.

Definition and Formula of Return on Investment

Select the Comparisons :

None ▼

Select the Ratio:

Return on Investment ROI▼

None ▼

Return on Investment ROI▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Investment	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Investment Change TTM	-6.57 %	-2.45 %	1.28 %	5.39 %	2.93 %
Y / Y Net Income Change TTM	-	-	-	-	-
Investment (TTM) in Millions	818	804	792	912	908
Return On Investment (TTM)	-22.61 %	-22.17 %	-21.39 %	-9.69 %	-10.43 %
GKOS's Overall Ranking	# 3293	# 2030	# 2539	# 2725	# 2472
Seq. Investment Change TTM	-2.62 %	-2.67 %	-2.97 %	1.6 %	1.66 %
Seq. Net Income Change TTM	-	-	-	-	-
Net Income (TTM) in Millions	-188	-189	-188	-88	-93

GKOS Company Profile >> Back to GKOS Roi Comparisons >> See Annual GKOS Return On Investment

Return On Investment GKOS's Ranking
Within:	No.
Industry	# 12
Sector	# 32
Overall	# 3293

Return On Investment Statistics
High	Average	Low
4.09 %	-9.33 %	-22.17 %
(Dec 31 2019)		(Mar 31 2026)

Financial Statements
Glaukos's II. Quarter Investments	$ 818 Millions	GKOS's Balance sheet
Glaukos's II. Quarter Income	$ -18 Millions	Quarterly GKOS's Income Statement
GKOS's Income by Division		See GKOS's Income by Division

GKOS Annual Return On Investment	(Dec 31 2025) 2025	(Dec 31 2024) 2024	(Dec 31 2023) 2023	(Dec 31 2022) 2022	(Dec 31 2021) 2021
Total Investments in Millions	792	900	866	930	986
Y / Y Investment Growth	-11.94 %	3.84 %	-6.84 %	-5.71 %	0.29 %
Net Income in Millions	-188	-146	-135	-99	-50
Y / Y Net Income Growth	-	-	-	-	-
Annual Return On Investment	-23.69 %	-16.27 %	-15.54 %	-10.67 %	-5.03 %

Annual Roi Comment

Definition and Formula of Return on Investment

Other ROI Ratios
Medical Equipment & Supplies Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
GKOS's Roi Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for GKOS's Competitors
Subscribers only: Roi for Glaukos's Suppliers
Subscribers only: Return On Investment for GKOS's Customers

Other Ratios
GKOS's Roa	GKOS's Inventory Turnover Ratio	GKOS's Growth Rates	GKOS's Dividend Statistics
	GKOS's Profitability Ratios	GKOS's Asset Turnover Ratio	GKOS's Dividend Growth
GKOS's Roe	GKOS's Valuation Ratios	GKOS's Financial Strength Ratios	GKOS's Dividend Payout Ratio

Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector

ROI

Date modified: 2026-09-12T06:19:57+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.